Nature Reviews Drug Discovery, Published online: 24 April 2024; doi:10.1038/d41573-024-00072-wRIPK3 inhibitor prevents lung damage in severe influenza infection

Nature Reviews Drug Discovery, Published online: 23 April 2024; doi:10.1038/d41573-024-00071-xmRNA therapy shows promise for metabolic disorder

Nature Reviews Drug Discovery, Published online: 18 April 2024; doi:10.1038/d41573-024-00070-yADAR-based editors that can change the mRNA code offer new opportunities in both rare genetic diseases and common complex ones.

Nature Reviews Drug Discovery, Published online: 17 April 2024; doi:10.1038/d41573-024-00069-5Robert Plenge, head of Research at Bristol Myers Squibb, discusses his vision of sequential immunotherapy for autoimmune diseases — including multiple sclerosis.

Nature Reviews Drug Discovery, Published online: 16 April 2024; doi:10.1038/d41573-024-00064-wThe antibody–drug conjugate landscape

Nature Reviews Drug Discovery, Published online: 15 April 2024; doi:10.1038/s41573-024-00920-9Immunogenic cell death (ICD) is crucial for the elicitation of anticancer immune responses by therapy, but the successful development of ICD-inducing treatments is hindered by various obstacles. This Review provides an overview of the core mechanisms of ICD,...